Products for Research Use Only

Tacrine

CAT: 0804-HY-111338-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-111338-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Tacrine is an effective oral acetylcholine (AChE) inhibitor (IC50 = 109 nM) and also acts as an active substrate for CYP1A2. Tacrine can restore cognitive dysfunction in elderly rats. Tacrine can cause liver toxicity and is used in research related to Alzheimer's disease[1][2][3][4].
CAS Number
321-64-2
UNSPSC
12352005
Hazard Statement
H301, H311, H315, H319, H331, H335, H351
Target
Cholinesterase (ChE)
Type
Reference compound
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/tacrine.html
Purity
99.75
Solubility
DMSO : ≥ 100 mg/mL
Smiles
NC1=C2CCCCC2=NC3=CC=CC=C31
Molecular Formula
C13H14N2
Molecular Weight
198.27
Precautions
H301, H311, H315, H319, H331, H335, H351
References & Citations
[1]Patocka J, et al. Possible role of hydroxylated metabolites of tacrine in drug toxicity and therapy of Alzheimer's disease. Curr Drug Metab. 2008;9 (4) :332-335.|[2]Bhatt S, et al. Assessment of the CYP1A2 Inhibition-Mediated Drug Interaction Potential for Pinocembrin Using In Silico, In Vitro, and In Vivo Approaches. ACS Omega. 2022;7 (23) :20321-20331. Published 2022 Jun 2.|[3]Romero A, et al. Novel tacrine-related drugs as potential candidates for the treatment of Alzheimer's disease. Bioorg Med Chem Lett. 2013;23 (7) :1916-1922.|[4]C Scali, et al. Tacrine administration enhances extracellular acetylcholine in vivo and restores the cognitive impairment in aged rats. Pharmacol Res. 1997 Dec;36 (6) :463-9.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
AChE
Citation 01
J Med Chem. 2025 Nov 27;68 (22) :24326-24357.|Bioorg Chem. 2024 Feb:143:107010.|Cell Death Dis. 2022 Jan 10;13 (1) :48.|Eur J Med Chem. 2024 Feb 5:265:116071.|J Enzyme Inhib Med Chem. 2023 Dec;38 (1) :2192439.|Drug Deliv. 2025 Dec 31;32 (1) :2585612.|Front Neurosci. 2020 May 28:14:458.|J Neurochem. 2025 Aug;169 (8) :e70178.

Popular Products